Our experimental system combining the human ASCT1/ASCT2 double knockout, ectopic expression of species-specific ASCT1 or ASCT2, and infection with pseudotyped vectors enabled comprehensive comparison of RDR group receptor usage. This evidence concerns the gene SLC1A4 and infection.